Concord Biotech Ltd
BSE:543960
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
C
|
Concord Biotech Ltd
BSE:543960
|
IN |
Wall St Price Targets
CONCORDBIO Price Targets Summary
Concord Biotech Ltd
According to Wall Street analysts, the average 1-year price target for CONCORDBIO is 1 224.1 INR with a low forecast of 1 030.28 INR and a high forecast of 1 470.12 INR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is CONCORDBIO's stock price target?
Price Target
1 224.1
INR
According to Wall Street analysts, the average 1-year price target for CONCORDBIO is 1 224.1 INR with a low forecast of 1 030.28 INR and a high forecast of 1 470.12 INR.
What is the Revenue forecast for Concord Biotech Ltd?
Projected CAGR
20%
Over the last 5 years, the compound annual growth rate for Revenue has been 11%. The projected CAGR for the next 6 years is 20%.
What is the Gross Profit forecast for Concord Biotech Ltd?
Projected CAGR
23%
Over the last 5 years, the compound annual growth rate for Gross Profit has been 8%. The projected CAGR for the next 3 years is 23%.
What is the Operating Income forecast for Concord Biotech Ltd?
Projected CAGR
32%
Over the last 5 years, the compound annual growth rate for Operating Income has been -1%. The projected CAGR for the next 3 years is 32%.
What is the Pre-Tax Income forecast for Concord Biotech Ltd?
Projected CAGR
44%
Over the last 5 years, the compound annual growth rate for Pre-Tax Income has been 2%. The projected CAGR for the next 2 years is 44%.
What is the Net Income forecast for Concord Biotech Ltd?
Projected CAGR
23%
Over the last 5 years, the compound annual growth rate for Net Income has been 2%. The projected CAGR for the next 3 years is 23%.
